Login
$ZURA
$1.05 -$0.03 (2.72%) After hours

$ZURA SEC Filings

Filed On Filing
09 Nov 2026 8-K: Other Events

Study did not meet primary endpoint of percentage change from baseline in total abscess and inflammatory nodule (AN) count at Week 16

03 Nov 2026 EFFECT
27 Oct 2026 FORM S-3
27 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

HENDERSON, Nev.--(BUSINESS WIRE)--October 27, 2026-- Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with seriou...

27 Oct 2026 10-Q
30 Sep 2026 FORM S-8
18 Aug 2026 144
17 Aug 2026 144
17 Aug 2026 8-K: Regulation FD Disclosure

2 Forward-Looking Statements Disclaimer This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate...

14 Aug 2026 144
13 Aug 2026 144
11 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

HENDERSON, Nev.--(BUSINESS WIRE)--August 11, 2026-- Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious...

11 Aug 2026 10-Q
01 Jul 2026 8-K: Regulation FD Disclosure

©2026 Zura Bio Ltd. 2 Forward-looking statements disclaimer This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as...

22 Jun 2026 Form 3: Mathew Marlyn Teresa, VP, Principal Acctg. Officer

Holds 129,182 shares of Class A Ordinary Shares

22 Jun 2026 Form 4: Jarrett Jennifer, Director

Granted 51,000 Share Option (Right to Buy)

22 Jun 2026 Form 4: Thiara Parvinder, Director

Granted 51,000 Share Option (Right to Buy)

22 Jun 2026 Form 4: Schoch Steven J, Director

Granted 51,000 Share Option (Right to Buy)

22 Jun 2026 Form 4: Nirula Ajay, Director

Granted 51,000 Share Option (Right to Buy)

22 Jun 2026 Form 4: Munshi Amit, Director

Granted 51,000 Share Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support